ArticleJMIR public health and surveillance2026
Transforming a Pandemic Tool Into a Public Health Asset: Modified Delphi Study.
Article in JMIR public health and surveillance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: During the COVID-19 pandemic, over 100 countries successfully deployed smartphone-based exposure notification (EN) apps alongside conventional contact tracing to mitigate the transmission of SARS-CoV-2. These systems enabled millions of COVID-19-positive individuals to anonymously alert community members of a potential exposure. Although evidence on EN program implementation is limited, leveraging expertise from public health professionals, academics, and global implementers from various disciplines can contribute to addressing this research gap. Objective: This study aimed to explore barriers and facilitators to adoption, identify optimal use cases for these tools, and understand how advancements in technology and policy might maximize EN utility for mitigating other infectious outbreaks. Methods: We used the Delphi method to develop a comprehensive online survey comprising closed-ended and open-ended questions. We considered consensus was reached when at least 75% of respondents selected "agree" or "strongly agree" for an item or statement. More than 30 global EN experts known to the investigators were invited to participate in the survey, and those who participated were asked to nominate or recruit others deemed eligible via a peer-to-peer method. We used descriptive and content analyses to summarize key findings from the survey. We invited the same experts to attend virtual focus groups to further probe their insights into the survey findings. Results: Twenty-two experts from 6 countries, including 10 experts from the United States, representing 3 continents, participated. Respondents were involved in the implementation of various EN technologies that encompassed varying levels of integration with existing public health agencies' infrastructure. Consensus was reached concerning the development of additional functionalities of the system, such as the ability for users to self-report a positive result from a SARS-CoV-2 at-home test, receive additional public health information from the app (ie, information on testing and social services), and receive general venue-based notifications concerning superspreader events. Other items that reached consensus included how the tool could be used for additional epidemiological purposes, such as expanding the technology to other airborne diseases, and the need for integration with surveillance data streams to augment analytics and forecasting. Conclusions: Global EN systems have the potential to be optimized for public health emergencies beyond COVID-19 and can be used as epidemiological surveillance tools in future disease outbreaks. Decision-makers and experts should revise existing protocols and seek to incorporate new functionality to alleviate the disease burden on both users and public health agencies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.